Current alarms detect wetness
Moisture clips are useful for some families, but they begin after urine reaches clothing or bedding.
Concept-stage medical device
A bladder alert before wet sheets.
DryNight is being developed as a lower-abdomen wearable and private wristband cue for children with nocturnal enuresis. The aim is to detect bladder filling early enough for a child, parent, or caregiver to act before moisture is detected.
- Stage
- Pre-prototype
- First use case
- Pediatric nocturnal enuresis
- Near-term work
- Signal feasibility and usability studies
Prototype direction
Lower-abdomen sensing, private haptic cue, caregiver alert only when needed.
- Lead signal
- Ultrasound feasibility
- Claim status
- Not validated
Problem
Bedwetting is treated like a behavior problem. It is a timing problem.
Most household tools respond after moisture appears. That delay turns a medical and developmental issue into laundry, embarrassment, and interrupted sleep. DryNight starts from a narrower question: can bladder filling be detected early enough to give the child a private cue?
The child often carries the burden
Cords, loud alarms, and repeated failures can make the child feel exposed instead of supported.
Caregivers need earlier information
A useful system gives a quiet signal before the event, not a louder signal after the damage is done.
Quantitative prevalence and market-size claims should be added only after primary-source verification.
Product direction
The first milestone is simple: detect filling early enough to act.
DryNight is being scoped as a soft lower-abdomen sensor, a child-worn haptic cue, and an optional caregiver alert. The product claim will only be earned after signal feasibility, usability, and clinical validation work.
- 01
Study the signal
Evaluate ultrasound and other noninvasive sensing methods against the practical realities of sleep, movement, skin contact, and body variation.
- 02
Build the wearable
Prototype a cordless sensor and wristband cue that a child can sleep with comfortably for repeated nights.
- 03
Validate the threshold
Test whether the system can distinguish bladder filling from noise early enough to wake the right person at the right time.
Product thesis
Measure bladder state, not wet fabric.
The starting technical hypothesis is that a lower-abdomen wearable can estimate bladder filling well enough to trigger a private pre-void cue. Ultrasound is the lead candidate because external academic work has explored abdomen-worn bladder monitoring, but DryNight will evaluate the best sensing path before locking hardware.
- Pediatric nocturnal enuresis as the first product focus
- Miniaturized ultrasound as the lead sensing candidate
- Bioimpedance and other noninvasive signals evaluated in parallel
- Cordless adhesive patch and private haptic wristband cue
- Data minimization from the first prototype
- Exploratory hardware conversations before partner claims are made
MEMS ultrasound
Private haptic cue
Data minimization
Current household tools
- Cord-and-clip moisture alarms
- Signal after wetness begins
- Public sound in a private moment
- Repeated cleanup after the event
DryNight thesis
- Cordless lower-abdomen sensing
- Signal before wetness begins
- Private cue to child or caregiver
- Design centered on dignity and sleep
Market focus
Start with the child who hides the sheets.
DryNight starts with pediatric nocturnal enuresis because the pain is specific, recurring, and poorly served by existing consumer tools. Adult incontinence remains a relevant expansion path, but the first proof point has to be narrow.
Primary market
Pediatric nocturnal enuresis.
The first user is a child who can sleep through a full bladder and a parent trying to help without shame. The initial product experience should be private, comfortable, and narrow enough to test rigorously.
- Market signal
- Families already buy alarms, mattress protection, and repeated workarounds
- Validation
- Bench testing, overnight usability, and pediatric continence input
Expansion market
Long-term care and aging.
The same type of early bladder signal could eventually support older adults and caregivers. That market has different workflows, liability, staffing constraints, and reimbursement questions, so it belongs after pediatric feasibility.
- Market signal
- Home care and long-term care once the signal is proven
- Validation
- Workflow interviews before committing to a care-facility study
Design standard
Not an alarm that tells a child he failed. A signal that gives him a chance.
Elvis Ndansi is building DryNight from a personal problem, but the company still has to meet the same evidence standard as any medical device.
Founder story
I wet the bed until I was twelve.
I grew up in Cameroon. My grandparents tried everything: raw okra, anthills, every remedy the village knew. Nothing worked. I stopped going to boarding school so no one would find out. I became the cleanest, most driven student I could be, because I was convinced no one could ever know what I was hiding at night.
Now my nine-year-old son wets the bed every night. His is more severe than mine. I refuse to shame him the way I was shamed. But the best alarms on Amazon still have cords, still detect moisture after the fact, still fail him.
So I started building what I wish I had. DryNight begins with my son, but the standard is broader: a child should not have to be wet before the system understands that help is needed.
Elvis Ndansi, Founder
Evidence status
The site should make clear what is known, and what still has to be proven.
DryNight is not presenting product performance data yet. The evidence plan starts with external precedent, hardware feasibility, usability, and then clinical validation. That sequence matters because investor confidence depends on the discipline of the claim.
External precedent
Academic groups have explored abdomen-worn bladder monitoring and pre-void alerting. DryNight will cite specific publications only after each claim is verified against the primary source.
Evidence review in progress
Sensor decision
Miniaturized ultrasound is the lead candidate, but the device architecture should stay open until bench testing compares signal quality, comfort, power, cost, and manufacturability.
Hardware path under review
Regulatory posture
No diagnostic, treatment, clearance, or approval claim belongs on the site until regulatory counsel and clinical advisors have reviewed the intended use.
Not cleared or approved
Clinical partners
The first partner conversations should focus on study design, family burden, usability, and the minimum evidence required before making commercial claims.
Partner with usTeam
A small team, with the missing seats named plainly.
EN
Elvis Ndansi
Founder & CEO
Founder of DryNight and author of Beyond Blames. He brings the lived experience, the book launch, and the urgency behind the first product question.
BT
Bryan Tegomoh, MD, MPH
Clinical and strategic advisor
Physician-epidemiologist supporting the clinical framing, evidence discipline, and early regulatory thinking.
Advisory roles we are actively recruiting
- Pediatric urology (clinical lead)
- Biomedical sensing and wearable engineering
- Regulatory affairs (medical devices)
- Contract manufacturing and supply
Technical conversations
Early and non-committed. Named partnerships should wait for signed agreements.
- Wearable engineering Exploratory discussions for sensor architecture, form factor, and manufacturability.
Contact
DryNight is early. The right conversations matter now.
The useful next step is not a waitlist count. It is a focused group of parents, clinicians, engineers, operators, and investors who can pressure-test the product before the claims get ahead of the evidence.
- Parents and families shape what "works" at 3 a.m.
- Clinicians and operators help us design studies that matter
- Engineers and researchers keep our technical claims honest
Investor inquiries should focus on feasibility, evidence plan, and the path to a defensible first prototype.